American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

BRAINSTORM CELL THERAPEUTICS INC. (BCLI)

$0.96 -4.00% OTC: BCLI · 15-min delayed

NEW YORK, New York
Public · OTC: BCLI

Visit website Follow

-$10.3MNet income

BCLIOTC

About BRAINSTORM CELL THERAPEUTICS INC.

BRAINSTORM CELL THERAPUTC

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Company facts

Type: Public · OTC: BCLI
Headquarters: NEW YORK, New York
Industry: Pharmaceuticals
Website: Visit site

Registry IDs

Ticker: BCLI OTC
SEC CIK: 1137883
EIN: 207273918
SIC: 2836 Biological Products, (No Diagnostic Substances)

Embed this company’s badge

Show Brainstorm Cell Therapeutics Inc.’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/brainstorm-cell-therapeutics-inc/"><img src="https://americancompanies.com/badge/brainstorm-cell-therapeutics-inc.svg" alt="Brainstorm Cell Therapeutics Inc. — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it, control the page, and earn the Verified badge.

Claim this profile

Track American companies

Create a free account to follow BRAINSTORM CELL THERAPEUTICS INC. and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Net income: -$10.3M
Total assets: $1.0M

Source: SEC EDGAR · updated Jun 7, 2026

Multi-year

Revenue & profit trend

FY2020

FY2021

FY2022

FY2023

FY2024

Revenue Net income

FY 2024

Financial statements

Income statement

Operating income: -$11.7M
Net income: -$11.6M
EPS (basic): $-2.31
EPS (diluted): $-2.31

Balance sheet

Total assets: $1.8M
Current assets: $385.0K
Total liabilities: $9.6M
Current liabilities: $9.0M
Shareholders’ equity: -$7.8M

Cash flow

Operating cash flow: -$9.1M
Investing cash flow: $12.0K
Financing cash flow: $8.0M
Net cash flow: -$1.1M

Statements via Polygon.io (SEC filings)

OTC: BCLI

$0.96 -4.00%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$0.48 $1.44

52-week range

EPS (diluted): $-2.31
Open: —
Day range: –
Prev close: —
Volume: —

Brainstorm Cell Therapeutics Inc. (BCLI) Stock Price

Reported a net loss of $10.3M.
Trading 33% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review BRAINSTORM CELL THERAPEUTICS INC..

Write a review

Newsroom

News about BRAINSTORM CELL THERAPEUTICS INC.

BrainStorm Cell Therapeutics Appoints Former FDA Associate Commissioner Peter J. Pitts to Board of Directors Benzinga · 2026-05-28 · positive BrainStorm Cell Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update Benzinga · 2026-05-15 · neutral BrainStorm Cell Therapeutics Announces Full Year 2025 Financial Results and Provides Corporate Update Benzinga · 2026-03-31 · positive Brainstorm Cell Therapeutics Secures Second $1 Million Strategic Placement; Total $2 Million Raised In February Benzinga · 2026-02-26 · positive Brainstorm Cell Therapeutics Announces $1 Million Strategic Financing at Premium to Market Benzinga · 2026-02-20 · positive BrainStorm Cell Therapeutics Announces Second Quarter 2025 Financial Results and Provides Corporate Update Benzinga · 2025-08-14 · neutral

News & sentiment via Polygon.io

FAQ

Brainstorm Cell Therapeutics Inc.: frequently asked questions

Is Brainstorm Cell Therapeutics Inc. an American company?

Brainstorm Cell Therapeutics Inc. is a US-based company headquartered in New York, New York, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Brainstorm Cell Therapeutics Inc. headquartered?

Brainstorm Cell Therapeutics Inc. is headquartered in New York, New York, United States.

Is Brainstorm Cell Therapeutics Inc. publicly traded?

Yes — Brainstorm Cell Therapeutics Inc. is a publicly traded company. Its stock trades under the ticker symbol BCLI on the OTC.

What does Brainstorm Cell Therapeutics Inc. do?

Brainstorm Cell Therapeutics Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore